The LLS Therapy Acceleration Program (TAP) is a strategic venture philanthropy initiative aimed at accelerating innovative blood cancer therapies while generating a return on investment. TAP collaborates with and makes equity investments in biotech companies to support the development of novel platforms, first-in-class assets addressing high unmet medical needs, emerging patient populations and orphan indications. Listen to a network of experts share their insights and experience on TAP.
Want to learn more? Visit https://lls.org/therapy-acceleration-program.
Want to learn more? Visit https://lls.org/therapy-acceleration-program.
- Category
- Oncology

Be the first to comment